Geo News
Community curated by people like you
Latest
AI
Crypto
Health
World Affairs
US Politics
STAT+: Kyverna Therapeutics plans to submit cell therapy for stiff person syndrome for FDA approval — Statnews
STAT+: Kyverna Therapeutics plans to submit cell therapy for stiff person syndrome for FDA approval
Statnews
View source article
Featured Stories
OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns
Aug 7, 2026
·
2 sources
STAT+: Kyverna Therapeutics plans to submit cell therapy for stiff person syndrome for FDA approval — Statnews